Pfizer-BioNTech start full U.S. approval application for COVID-19 vaccine – Reuters
1 min readPfizer-BioNTech start full U.S. approval application for COVID-19 vaccine – Reuters
Pfizer Inc and German partner BioNTech SA said on Friday they have started an application process with the U.S. Food and Drug Administration for full approval of their COVID-19 vaccine, currently only authorized for emergency use.